关键词: 胰腺导管腺癌, 可能切除, 共识

Abstract:

Interpretation of international consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017        SUN Bei, YANG Wen-bo, HU Ji-sheng. Department of Pancreatic and Biliary Surgery, the First Affiliated Hospital of Harbin Medical University, Harbin 150001,China
Corresponding author：Sun Bei,E-mail：sunbei70@tom.com
Abstract Borderline resectable pancreatic ductal adenocarcinoma(BR-PDAC), characterized by high risk for positive margin with resection, high post-operative recurrence rate and poor prognosis, is a special kind of pancreatic ductal adenocarcinoma between resectable and nonresectable type. Neoadjuvant multimodality therapy is recommended as the first approach in recent years. To address related issues and seek an international consensus on BR-PDAC, a symposium was arranged during the 20th meeting of the International Association of Pancreatology (IAP) held in Sendai, Japan, in 2016. Finally, the definition of BR-PDAC is based on three distinct dimensions: anatomical (A), biological (B) and conditional (C), and requires one or more positive dimensions(e.g. A, B, C, AB, AC, BC or ABC). The present consensus acknowledges that resectability is not just determined by anatomic relationship between the tumor and vessels, but that biological and conditional factors are also important.

Key words: pancreatic ductal adenocarcinoma, borderline resectable, consensus